Nuclease P1 Antibody from Cusabio |
1-CSB-PA328459LA01PEU | [
100ug: 380.40 EUR ]
[
50ug: 402.00 EUR ]
|
|
Description: A polyclonal antibody against Nuclease P1. Recognizes Nuclease P1 from Penicillium citrinum. This antibody is Unconjugated. Tested in the following application: ELISA |
Nuclease P1 Antibody from Abbexa |
20-abx300888 | [
100 ug: 493.20 EUR ]
[
1 mg: 2214.00 EUR ]
[
200 ug: 718.80 EUR ]
[
20 ug: 218.40 EUR ]
[
50 ug: 360.00 EUR ]
|
|
Nuclease P1 Antibody (HRP) from Abbexa |
20-abx300889 | [
100 ug: 493.20 EUR ]
[
1 mg: 2214.00 EUR ]
[
200 ug: 718.80 EUR ]
[
20 ug: 218.40 EUR ]
[
50 ug: 360.00 EUR ]
|
|
Nuclease P1 Antibody (FITC) from Abbexa |
20-abx300890 | [
100 ug: 493.20 EUR ]
[
1 mg: 2214.00 EUR ]
[
200 ug: 718.80 EUR ]
[
20 ug: 218.40 EUR ]
[
50 ug: 360.00 EUR ]
|
|
Nuclease P1 Antibody (Biotin) from Abbexa |
20-abx300891 | [
100 ug: 493.20 EUR ]
[
1 mg: 2214.00 EUR ]
[
200 ug: 718.80 EUR ]
[
20 ug: 218.40 EUR ]
[
50 ug: 360.00 EUR ]
|
|
Nuclease P1 Polyclonal Antibody from EpiGentek |
A64318 | [
100 µg: 684.66 EUR ]
[
20 ul: 117.70 EUR ]
[
50 ul: 302.50 EUR ]
[
100 ul: 423.50 EUR ]
|
|
Penicillium citrinum Nuclease P1 from Cusabio |
1-CSB-EP328459PEU | [
100ug: 733.20 EUR ]
[
10ug: 370.80 EUR ]
[
1MG: 2192.40 EUR ]
[
200ug: 1126.80 EUR ]
[
500ug: 1461.60 EUR ]
[
50ug: 476.40 EUR ]
|
|
Description: Recombinant Penicillium citrinum Nuclease P1 expressed in E.coli |
Penicillium citrinum Nuclease P1 from Cusabio |
1-CSB-EP328459PEUa0 | [
100ug: 733.20 EUR ]
[
10ug: 370.80 EUR ]
[
1MG: 2192.40 EUR ]
[
200ug: 1126.80 EUR ]
[
500ug: 1461.60 EUR ]
[
50ug: 476.40 EUR ]
|
|
Description: Recombinant Penicillium citrinum Nuclease P1 expressed in E.coli |
Penicillium citrinum Nuclease P1 from Cusabio |
1-CSB-YP328459PEU | [
100ug: 814.80 EUR ]
[
10ug: 402.00 EUR ]
[
1MG: 2606.40 EUR ]
[
200ug: 1261.20 EUR ]
[
500ug: 1730.40 EUR ]
[
50ug: 522.00 EUR ]
|
|
Description: Recombinant Penicillium citrinum Nuclease P1 expressed in Yeast |
Nuclease P1 Antibody, HRP conjugated from Cusabio |
1-CSB-PA328459LB01PEU | [
100ug: 380.40 EUR ]
[
50ug: 402.00 EUR ]
|
|
Description: A polyclonal antibody against Nuclease P1. Recognizes Nuclease P1 from Penicillium citrinum. This antibody is HRP conjugated. Tested in the following application: ELISA |
Nuclease P1 Antibody, FITC conjugated from Cusabio |
1-CSB-PA328459LC01PEU | [
100ug: 380.40 EUR ]
[
50ug: 402.00 EUR ]
|
|
Description: A polyclonal antibody against Nuclease P1. Recognizes Nuclease P1 from Penicillium citrinum. This antibody is FITC conjugated. Tested in the following application: ELISA |
Nuclease P1 from Penicillium citrinum from Jaica |
OPNUCP1 | 500 units/vial: 545.00 EUR |
|
Nuclease P1 Antibody, Biotin conjugated from Cusabio |
1-CSB-PA328459LD01PEU | [
100ug: 380.40 EUR ]
[
50ug: 402.00 EUR ]
|
|
Description: A polyclonal antibody against Nuclease P1. Recognizes Nuclease P1 from Penicillium citrinum. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Recombinant Penicillium citrinum Nuclease P1 from SAB |
AP74245 | each: Ask for price |
|
Recombinant Penicillium citrinum Nuclease P1 from Cusabio |
CSB-EP328459PEU | 2951 mg: Ask for price |
|
Recombinant Penicillium citrinum Nuclease P1 from Cusabio |
CSB-EP328459PEUa0 | 2952 mg: Ask for price |
|
Recombinant Penicillium citrinum Nuclease P1 from Cusabio |
CSB-EP328459PEUb1 | 11327 mg: Ask for price |
|
Recombinant Penicillium citrinum Nuclease P1 from Cusabio |
CSB-YP328459PEU | 6230 mg: Ask for price |
|
Nuclease P1 rabbit polyclonal antibody, Biotin from Origene Technologies GmbH |
AP21351BT-N | 1 ml: Ask for price |
|
Nuclease P1 Polyclonal Antibody, HRP Conjugated from EpiGentek |
A64319 | [
100 µg: 684.66 EUR ]
[
50 ul: 302.50 EUR ]
[
100 ul: 423.50 EUR ]
|
|
Nuclease P1 Polyclonal Antibody, FITC Conjugated from EpiGentek |
A64320 | [
100 µg: 684.66 EUR ]
[
50 ul: 302.50 EUR ]
[
100 ul: 423.50 EUR ]
|
|
OPCA03259-20UG - Nuclease P1 Recombinant Protein from Aviva Systems Biology |
OPCA03259-20UG | 20ug: 449.00 EUR |
|
Nuclease P1 Polyclonal Antibody, Biotin Conjugated from EpiGentek |
A64321 | [
100 µg: 684.66 EUR ]
[
50 ul: 302.50 EUR ]
[
100 ul: 423.50 EUR ]
|
|
OPCA03259-100UG - Nuclease P1 Recombinant Protein from Aviva Systems Biology |
OPCA03259-100UG | 100ug: 668.00 EUR |
|
OPCA03259-500UG - Nuclease P1 Recombinant Protein from Aviva Systems Biology |
OPCA03259-500UG | 500ug: 1534.00 EUR |
|
Nuclease P1 rabbit polyclonal antibody, Azide Free from Origene Technologies GmbH |
AP21351AF-N | 10 mg: Ask for price |
|
Cas9 Nuclease from GeneOn |
310 | 2x40µg (2x250 pmol): 316.80 EUR |
|
Cas9 Nuclease from GeneOn |
312HC | 80 µg (500 pmol): 268.80 EUR |
|
Cas9 Nuclease from GeneOn |
314HC | 400 µg (2500 pmol): 894.00 EUR |
|
Cas9 Nuclease from Vazyme |
EN301-01 | 50 pmol: 146.40 EUR |
|
Cas9 Nuclease from Vazyme |
EN301-02 | 250 pmol: 184.80 EUR |
|
Nuclease AWAY from Biomatik Corporation |
A6257-100ML | 100ML: 22.00 EUR |
|
Description: Biotechnology |
Nuclease AWAY from Biomatik Corporation |
A6257-500ML | 500ML: 88.00 EUR |
|
Description: Biotechnology |
Turbo Nuclease from Jena Bioscience GmbH |
EN-180L | 5 x 10000units: 384.50 EUR |
|
Description: Serratia marcescens, recombinant, E. coli |
Turbo Nuclease from Jena Bioscience GmbH |
EN-180S | 10000units: 96.20 EUR |
|
Description: Serratia marcescens, recombinant, E. coli |
Ultra Nuclease from HZymes Biotechnology |
HBP000106 | 20μL: 14.73 EUR |
|
Ultra Nuclease from HZymes Biotechnology |
HBP000107 | 200μL: 116.82 EUR |
|
Ultra Nuclease from HZymes Biotechnology |
HBP000108 | 2mL: 965.04 EUR |
|
Ultra Nuclease from HZymes Biotechnology |
HBP000109 | 20mL: 8634.56 EUR |
|
Microccal Nuclease from Tribioscience |
TBS6020 | 10KU: 89.00 EUR |
|
Nuclease Mix 0.5mL from Scientific Laboratory Supplies |
80650142 | EACH: 170.40 EUR |
|
Water, Nuclease Free from Bio-WORLD |
42300012-1 | 1 L: 60.10 EUR |
|
Water, Nuclease Free from Bio-WORLD |
42300012-2 | 4 L: 81.44 EUR |
|
Water, Nuclease Free from Bio-WORLD |
42300012-3 | 125 mL: 10.94 EUR |
|
Water, Nuclease Free from Bio-WORLD |
42300012-4 | 250 mL: 18.58 EUR |
|
Water, Nuclease Free from Bio-WORLD |
42300012-5 | 500 mL: 33.95 EUR |
|
Water, Nuclease Free from Bio-WORLD |
42300012-8 | 8 L: 173.72 EUR |
|
Nuclease-free H2O from Abclonal |
RK20102 | 25mL: 21.50 EUR |
|
Benzonase Nuclease, 99% from ProSpec Tany |
enz-1112 | 5000U: 90.00 EUR |
|
Description: Recombinant Serratia Marcescens Benzonase Nuclease, 99% |
Benzonase Nuclease, 90% from ProSpec Tany |
enz-1150 | 5000U: 70.00 EUR |
|
Description: Recombinant Serratia Marcescens Benzonase Nuclease, 90% |
Cas9 Nuclease Protein from ABM |
K008 | 8.0 µg (50pmol) Volume: 50µL: 40.00 EUR |
|
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. |
saCas9 Nuclease Protein from ABM |
K044 | 6.5 µg (50pmol) Volume: 50µL: 55.00 EUR |
|
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Staphylococcus aureus, abbreviated saCas9, is gaining popularity as an alternative to spCas9 due to its relatively smaller size. The saCas9 PAM sequence is 5’-NNGRRN (preferably 5’-NNGRRT). |
Cas9 Nuclease - 400µg - 1,600 ng/µl from Intact Genomics |
3276-(HC) | 1/EA: 678.00 EUR |
|
Cas9 Nuclease Lentivirus from ABM |
K003 | 300 µl, 10^7 IU/ml, Titer: 10^7 IU/ml: 315.00 EUR |
|
Description: N/A |
Cas9 Nuclease Adenovirus from ABM |
K004 | 1.0 ml, 10^6 pfu/ml, Titer: 10^6 pfu/ml: 315.00 EUR |
|
Description: N/A |
Cas9 Nuclease - 80µg - 1,600 ng/µl from Intact Genomics |
3273-(HC) | 1/EA: 226.80 EUR |
|
Cas9 Nuclease NLS Protein from ABM |
K030 | 8.0 µg (50pmol) Volume: 50µL: 40.00 EUR |
|
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR).;;The Cas9 nuclease from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. The reason for spCas9 popularity is two-fold. First the spCas9 PAM sequence is 5’-NGG, which is highly abundant in the genome allowing virtually any gene to be targeted. The spCas9 enzyme also has on average a higher efficiency in vivo compared to other variants. Cas9 Nuclease NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein. |
Rabbit polyclonal antibody to Apoptosis-enhancing nuclease (apoptosis enhancing nuclease) from Origene Technologies GmbH |
TA308608 | 100 µl: Ask for price |
|
fnCpf1 Nuclease NLS Protein from ABM |
K087 | 38 μg (250 pmol) Volume: 25µL: 75.00 EUR |
|
Description: Using Cpf1 (a.k.a. Cas12a) in your CRISPR experiment offers several advantages over other CRISPR-associated nucleases.; - Due to the T-rich PAM sequence (TTTN), Cpf1 enables editing in regions unable to be targeted by Cas9.
- Cpf1 can be used with a shorter guide RNA (called crRNA) than Cas9.
- Cpf1 creates a staggered cut in dsDNA instead of a blunt cut.
- Cpf1 cuts distal to the PAM sequence, which may allow for multiple rounds of cleavage.
fnCpf1 is from the bacteria Francisella novicida. This protein contains a SV40 T antigen nuclear localization signal (NLS) on the N-terminus of the protein. If the cut caused by fnCpf1 is repaired by non-homologous end joining (NHEJ), an indel may be formed that disrupts the open reading frame of the targeted gene, leading to gene knockout. Alternatively, by supplying a repair template, a sequence can be knocked in at the cleavage site via homology directed repair (HDR).
|
Nuclease Decontamination Solution from Bio-WORLD |
43094006-1 | 250 mL: 43.46 EUR |
|
Universal Nuclease ELISA Kit from Abclonal |
RK04660 | 96T: 280.00 EUR |
|
Bovine Albumin Nuclease Free from Innovative research |
IBOALBNF100MG | each: 136.00 EUR |
|
Description: Bovine Albumin Nuclease Free |
Bovine Albumin Nuclease Free from Innovative research |
IBOALBNF500MG | each: 347.00 EUR |
|
Description: Bovine Albumin Nuclease Free |
Recombinant Human APEX nuclease-1 from CHI Scientific |
7-02476 | 2µg: Ask for price |
|
Recombinant Human APEX nuclease-1 from CHI Scientific |
7-02477 | 10µg: Ask for price |
|
Recombinant Human APEX nuclease-1 from CHI Scientific |
7-02478 | 1mg: Ask for price |
|
Cas9 Nuclease Lentiviral Vector from ABM |
K002 | 10 ug: 184.80 EUR |
|
GENIUS™Nuclease DMF Filed from ACROBIOSYSTEMS |
BEE-N3116 | 500KU: 96.30 EUR |
|
Description: GENIUS™Nuclease is a recombinant form of Serratia macescens extracellular endonuclease produced in Escherichia coli cells using a proprietary process at ACRObiosystems. GENIUS™Nuclease is a homodimer with monomer molecular masses about 30 kDa. Two disulfide bonds found in the nuclease are crucial to its activity and stability. The enzyme is a non-specific nuclease with high specific activity, which degrades both single- and double-stranded nucleic acids in any form ( single stranded, double stranded, linear, circular and supercoiled ). It hydrolyzes internal phosphodiester bonds present between the nucleotides to 5‘- phosphorylated oligonucleotides of 3-5 bases in length. |
Cas9 Nuclease GFP NLS Protein from ABM |
K048 | 9.5 µg (50pmol) Volume: 50µL: 55.00 EUR |
|
Description: The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 system is the latest RNA-guided, endonuclease tool in genome editing which allows for very specific genomic disruption and replacement. ;The Cas9 nuclease serves to unwind the genomic DNA duplex next to conserved protospacer adjacent motifs (PAMs) and homes in on its target sequence, which is recognized by a complementary single-guide RNA. The resulting double-stranded break gets repaired by the non-homologous end joining (NHEJ) pathway, leading to a disruption in the open reading frame of the targeted gene. Alternatively, by supplying a suitable repair template, virtually any desired point mutation can be introduced at the break point via homology-directed repair (HDR). ;The Cas9 from the bacteria Streptococcus pyogenes, abbreviated spCas9, is the most commonly used Cas9 variant. ;The fusion of Cas9 Nuclease NLS to GFP allows for visual confirmation of transfection as well as subsequent verification of Cas9 clearance from the cells. Cas9 Nuclease-GFP can also be used for FACS applications and screening. Cas9 Nuclease-GFP NLS contains a SV40 T antigen nuclear localization sequence (NLS) on the C-terminus of the protein. Our Cas9-GFP proteins have the Enhanced green fluorescent protein (eGFP). |
saCas9 Nuclease AAV Virus (AAV1) from ABM |
K208 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
saCas9 Nuclease AAV Virus (AAV2) from ABM |
K209 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
saCas9 Nuclease AAV Virus (AAV3) from ABM |
K210 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
saCas9 Nuclease AAV Virus (AAV4) from ABM |
K211 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
saCas9 Nuclease AAV Virus (AAV5) from ABM |
K212 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
saCas9 Nuclease AAV Virus (AAV6) from ABM |
K213 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
saCas9 Nuclease AAV Virus (AAV7) from ABM |
K214 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
saCas9 Nuclease AAV Virus (AAV8) from ABM |
K215 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
saCas9 Nuclease AAV Virus (AAV9) from ABM |
K216 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
Ultra Nuclease Assay Kit(ELISA) from HZymes Biotechnology |
HBP000111 | 96 Tests: 609.50 EUR |
|
anti-Apoptosis enhancing nuclease from Abfrontier |
YF-PA20583 | 50 ug: 435.60 EUR |
|
Description: Mouse polyclonal to Apoptosis enhancing nuclease |
saCas9 Nuclease AAV Virus (AAV10) from ABM |
K217 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
saCas9 Nuclease AAV Virus (AAV11) from ABM |
K218 | 2 x 250 µl, 1 x 10^9 GC/ml, Titer: 1 x 10^9 GC/ml: 375.00 EUR |
|
Description: This AAV vector expresses the Cas9 orthologue from Staphylococcus Aureus (saCas9). saCas9 is ~1 kb shorter than spCas9, allowing it to be efficiently packaged in AAV Virus. Furthermore, the saCas9 enzyme recognizes a longer PAM sequence than spCas9, and thus has greater editing specificity.AAV has low immunogenicity and broad host range, making it an ideal choice for both in vivo and in vitro applications. Use this saCas9-expressing AAV virus with a target-specific saCas9-compatible sgRNA for highly specific and efficient genome editing. |
GENIUS™ Nuclease, premium grade from ACROBIOSYSTEMS |
NUE-S5119 | 5000KU: 1358.90 EUR |
|
Description: GENIUS™ Nuclease, premium grade is a tag free recombinant form of Serratia marcescens extracellular endonuclease produced in Escherichia coli cells using a proprietary process at ACRObiosystems. GENIUS™ Nuclease, premium grade is a homodimer with monomer molecular masses about 30 kDa with an isoelectric point (pI) at pH 6.85. The enzyme is a non-specific nuclease with high specific activity, which degrades both single- and double-stranded nucleic acids in any form (single stranded, double stranded, linear, circular and supercoiled). It hydrolyzes internal phosphodiester bonds present between the nucleotides to 5’- phosphorylated oligonucleotides of 3-5 bases in length. |
Cas9 Nuclease Non-Viral Vector from ABM |
K095 | 10 μg, Titer: N/A: 135.00 EUR |
|
Description: N/A |
Apoptosis enhancing nuclease antibody from Fitzgerald |
70R-13466 | 100 ul: 548.40 EUR |
|
Description: Affinity purified Rabbit polyclonal Apoptosis enhancing nuclease antibody |
Rat APEX Nuclease 1 ELISA Kit from Innovative research |
IRTAPEX1KT | each: 790.00 EUR |
|
Description: Rat APEX Nuclease 1 ELISA Kit |
Apoptosis-enhancing nuclease antibody from SAB |
22725-100ul | 100ul: 468.00 EUR |
|
Apoptosis-enhancing nuclease antibody from SAB |
22725 | 100ul: 479.00 EUR |
|